Lemtrada

Alemtuzumab

9.4 High risk

Lemtrada & White blood cell count decreased

4.4%

of users reported White blood cell count decreased

57.6%

also reported Severe reaction

70.6%

are women

Most common medical consequences

Severe reaction
57.6%
Hospitalization
37.3%
Disability
2.3%
Death
1.4%
Life-threatening condition
1.4%

Have you experienced any negative side effects from this medication?

Lemtrada: general information

Most common side effects (150)

Most commonly affected ages

10 - 19 years
0.7%
20 - 29 years
15.0%
30 - 39 years
33.3%
40 - 49 years
28.7%
50 - 59 years
17.2%
60 - 69 years
4.9%
70 - 79 years
0.3%